REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
OREANA NIPD GENETICS NEONATAL SCREENING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
03/31/2026
Trademark type
Combined
Nice classes
1, 42, 44
Filing date
06/08/2020
Registration date
03/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
84
Owner location
CY
Examiner
MESSICK, TABITHA LEE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "NIPD GENETICS" in gray with the large centered wording "OREANA" in teal below. Further below the wording "NEONATAL SCREEING" is in gray.
Holders and representatives
Holders
MEDICOVER PUBLIC CO LTD
NIPD Genetics Public Company Limited
Representatives
Paulo A. de Almeida Patel & Almeida PC
Technical classification
Nice Classes
Class 1Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Kits composed of reagents for genetic testing for medical and scientific research purposes; kits composed of reagents for genetic testing for medical and scientific research purposes in the field of human genetics; kits composed of reagents for neonatal testing for medical and scientific research purposes; kits composed of reagents for testing for neonatal sub-chromosomal abnormalities and monogenic diseases for medical and scientific research purposes
Class 42
Medical laboratory services for neonatal testing of newborn genetic abnormalities; design and development of medical screening tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing of newborns; genetic testing for scientific research and analysis purposes in the field of human reproduction; neonatal testing for scientific research purposes; testing for neonatal genetic abnormalities for research purposes; scientificlaboratoryclinicalmedicaltechnological research and analysis services in the field of neonatal genetic testing
Class 44
Medical neonatal genetic testing services for screening of newborn genetic abnormalities; medical neonatal genetic screening testing; medical neonatal genetic testing; medical testing for screening of genetic disordersdiseases and syndromes in particular in newborns; genetic testing for medical purposes and genetic counseling in the field of human genetics for medical purposes
Publications
History of USPTO decisions and trademark events.
41 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/16/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/14/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/02/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/23/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/23/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/23/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/08/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/16/2021
FIMP
FINAL DISPOSITION PROCESSED
07/16/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2021
PUBO
PUBLISHED FOR OPPOSITION
01/12/2021
GPNX
NOTIFICATION PROCESSED BY IB
01/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/23/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/23/2020
RFNT
REFUSAL PROCESSED BY IB
12/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/01/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/01/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/01/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/13/2020
RFRR
REFUSAL PROCESSED BY MPU
11/12/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/24/2020
CNRT
NON-FINAL ACTION WRITTEN
10/23/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2020
DOCK
ASSIGNED TO EXAMINER
10/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/15/2020
Continuous trademark protection
Get notified about every new filing that threatens OREANA NIPD GENETICS NEONATAL SCREENING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.